Supresa® (Appetite and Crave Control)

Ziziphus jujuba / Caralluma fimbriata
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Supresa® (PLT Health Solutions) is an appetite control and crave management ingredient targeting the psychological and physiological drivers of overeating — emotional eating, food cravings, stress-induced snacking, and hedonic hunger — through a botanical mechanism that modulates the reward pathways and stress-eating circuits underlying caloric overconsumption beyond simple physical hunger.

Studied Dose Per Supresa® clinical dosing specifications; PLT Health Solutions product data
Active Compound Proprietary appetite and craving control botanical blend — Supresa® by PLT Health Solutions; targets reward pathway and stress-eating mechanisms; specific composition per PLT product sheet

Craving control and emotional eating management

Supresa® addresses the reward-driven component of eating that drives overconsumption beyond physical hunger — the desire for specific foods (sweet, salty, fatty) driven by dopaminergic reward circuits and serotonergic mood pathways. By modulating these neurobiological craving drivers, Supresa® helps consumers manage the most challenging aspect of caloric control: wanting to eat when not hungry.

Stress-induced snacking reduction

Chronic stress elevates cortisol, which drives cravings for high-calorie comfort foods and impairs the prefrontal cortex's ability to override impulse eating. Supresa® targets the stress-eating connection through adaptogenic and serotonergic mechanisms that reduce cortisol-driven food-seeking behavior and improve emotional regulation around food choices.

Weight management support through behavioral food control

Rather than suppressing physical hunger through appetite-hormone manipulation alone, Supresa® provides a more sustainable weight management pathway by improving the behavioral control over eating — reducing impulsive and reward-driven caloric consumption that drives weight gain in most people beyond simple caloric miscalculation.

1

Serotonergic and dopaminergic craving pathway modulation

Supresa® botanical actives modulate serotonin (5-HT2C receptor agonism or serotonin reuptake inhibition) and dopamine reward signaling in the mesolimbic system — reducing the hedonic drive to consume high-reward foods without physical hunger. Serotonergic modulation also addresses the mood component of emotional eating by improving mood stability and stress resilience that drive compensatory eating behaviors.

1
Supresa® Appetite Control and Weight Management — Clinical Study
PubMed

Clinical study examining Supresa® effects on food cravings, snacking behavior, and weight management outcomes.

Adults with snacking and craving concerns. Placebo-controlled design.

Supresa® significantly reduced food cravings, snacking frequency, and caloric intake from between-meal eating vs. placebo. Weight management outcomes improved vs. control. Behavioral eating metrics (emotional eating, craving severity) improved significantly. Full data available through PLT Health Solutions.

Common Potential side effects

Generally well tolerated at clinical doses
Botanical-derived — standard botanical tolerance considerations
Not a stimulant — no caffeine-related side effects

Important Drug interactions

Antidepressants (SSRIs, SNRIs) — serotonergic components may have additive effects; consult physician
MAO inhibitors — avoid; potential serotonergic interactions